Mastitis continues to be the most important economic risk for dairy farmers, accounting for about 40% of the total direct costs of the common production diseases. This technology is a biological approach to mastitis prevention based on a special combination of probiotic bacteria, leading to a protection against the majority of pathogenic bacteria for mastitis.
Current treatment, both for prophylaxis and therapy, rely heavily on antibiotics, which is costly and frequently ineffective due to the overuse of antibiotics in veterinary medicine resulting in antibiotic resistance. Recent legislation in the EU are restricting the use of antibiotics in animals leading to greater controls and limitations in their use. Thus, there is an unmet need for alternative therapies.
Scientists at the University of Applied Sciences and Arts Hannover developed a probiotic teat dip as an active way to protect the teat ends against pathogenic bacteria. The special formulation is based on a combination of non-pathogenic probiotic bacteria, which protects the teats against major pathogens of mastitis.
In vitro and in vivo proof of concept in a first dairy farm field study.
An international patent application has been filed (Applicant: University of Applied Sciences and Arts Hannover).
Dr. Stefan Uhle
Patent Manager Life Science
Tel: +49 551 30724 154